Half-year report · Q2

Period2025-01-01 → 2025-06-30
Filed2025-11-06
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed

Amends S100WFZ4. Amended by S100WZC4 (2025-11-06).

Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥1.73T2025-01-01 → 2025-06-30Cons.Revenue IFRS
Revenue¥3.15T2024-01-01 → 2024-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.57T2024-01-01 → 2024-06-30Cons.Revenue IFRS
Operating income¥479.9bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Operating income¥432.7bn2024-01-01 → 2024-06-30Cons.Operating profit loss IFRS
Profit before tax¥437.8bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Profit before tax¥233.8bn2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥399.1bn2024-01-01 → 2024-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥319.9bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥179.2bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥305.2bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥322.0bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Net income¥182.6bn2024-01-01 → 2024-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥307.1bn2024-01-01 → 2024-06-30Cons.Profit loss IFRS
Total assets¥8.26Tat 2025-06-30Cons.Assets IFRS
Total assets¥8.37Tat 2024-12-31Cons.Assets IFRS
Total assets¥7.87Tat 2024-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥4.12Tat 2025-06-30Cons.Liabilities IFRS
Total liabilities¥4.52Tat 2024-12-31Cons.Liabilities IFRS
Net assets / equity¥4.14Tat 2025-06-30Cons.Equity IFRS
Net assets / equity¥3.85Tat 2024-12-31Cons.Equity IFRS
Net assets / equity¥4.53Tat 2024-06-30Cons.Equity IFRS
Net assets / equity¥3.91Tat 2023-12-31vCons.Equity IFRS
Equity (owners)¥4.06Tat 2025-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.77Tat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥865.2bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.08Tat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.09Tat 2024-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.04Tat 2023-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥167.5bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥630.0bn2024-01-01 → 2024-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥260.2bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥132.0bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥439.8bn2024-01-01 → 2024-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥28.7bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥230.9bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥94.9bn2024-01-01 → 2024-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥267.5bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥180.192025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥100.952024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥171.892024-01-01 → 2024-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥180.172025-01-01 → 2025-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥100.942024-01-01 → 2024-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥171.862024-01-01 → 2024-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio49.1%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.0%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio56.4%at 2024-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥686m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥1.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥23.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥23.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥23.9bn
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥1.9bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥1.9bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30¥24m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30¥24m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30¥24m
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥48.3bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥48.3bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥4.2bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥4.2bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30−¥20.2bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue2025-01-01 → 2025-06-30¥76.8bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue external2025-01-01 → 2025-06-30¥76.7bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥14m
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2025-01-01 → 2025-06-30¥2.6bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2025-01-01 → 2025-06-30¥2.6bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2025-01-01 → 2025-06-30¥3.0bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue2025-01-01 → 2025-06-30¥1.61T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue external2025-01-01 → 2025-06-30¥1.61T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥0
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2025-01-01 → 2025-06-30¥556.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2025-01-01 → 2025-06-30¥556.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2025-01-01 → 2025-06-30¥520.9bn
—segment totalrevenue2025-01-01 → 2025-06-30¥1.73T
—segment totalrevenue external2025-01-01 → 2025-06-30¥1.73T
—segment totalrevenue intersegment2025-01-01 → 2025-06-30¥14m
—segment totalsegment profit2025-01-01 → 2025-06-30¥562.9bn
—segment totalsegment profit2025-01-01 → 2025-06-30¥562.9bn
—segment totalsegment profit2025-01-01 → 2025-06-30¥503.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-06-30¥658m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-06-30¥1.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥27.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥27.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥25.3bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30−¥1.7bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30−¥1.7bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30¥24m
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-06-30¥44.1bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-06-30¥44.1bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.0bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.0bn
jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.0bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue2024-01-01 → 2024-06-30¥73.8bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue external2024-01-01 → 2024-06-30¥73.8bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥13m
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.4bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.4bn
jpcrp040300-q2r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-06-30¥4.3bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue2024-01-01 → 2024-06-30¥1.45T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue external2024-01-01 → 2024-06-30¥1.45T
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥182m
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-06-30¥472.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-06-30¥472.1bn
jpcrp040300-q2r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-06-30¥449.6bn
—segment totalrevenue2024-01-01 → 2024-06-30¥1.57T
—segment totalrevenue external2024-01-01 → 2024-06-30¥1.57T
—segment totalrevenue intersegment2024-01-01 → 2024-06-30¥196m
—segment totalsegment profit2024-01-01 → 2024-06-30¥480.5bn
—segment totalsegment profit2024-01-01 → 2024-06-30¥480.5bn
—segment totalsegment profit2024-01-01 → 2024-06-30¥458.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 980
ItemContextValueUnit
Other financial liabilities ncl IFRSPrior1YearInstant49210000000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant49716000000JPY
Retirement benefit liability ncl IFRSPrior1YearInstant277236000000JPY
Retirement benefit liability ncl IFRSCurrentQuarterInstant273357000000JPY
Provisions ncl IFRSPrior1YearInstant253949000000JPY
Provisions ncl IFRSCurrentQuarterInstant244755000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant120427000000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant111528000000JPY
Deferred tax liabilities IFRSPrior1YearInstant124455000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant127329000000JPY
Non current labilities IFRSPrior1YearInstant2373398000000JPY
Non current labilities IFRSCurrentQuarterInstant2246639000000JPY
Liabilities IFRSPrior1YearInstant4522005000000JPY
Liabilities IFRSCurrentQuarterInstant4120948000000JPY
Share capital IFRSPrior1YearInstant100000000000JPY
Share capital IFRSCurrentQuarterInstant100000000000JPY
Capital surplus IFRSPrior1YearInstant736697000000JPY
Capital surplus IFRSCurrentQuarterInstant737065000000JPY
Treasury shares IFRSPrior1YearInstant-488579000000JPY
Treasury shares IFRSCurrentQuarterInstant-489705000000JPY
Other components of equity IFRSPrior1YearInstant381599000000JPY
Other components of equity IFRSCurrentQuarterInstant527574000000JPY
Retained earnings IFRSPrior1YearInstant3036905000000JPY
Retained earnings IFRSCurrentQuarterInstant3184646000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant3766623000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant4059580000000JPY
Non controlling interests IFRSPrior1YearInstant82104000000JPY
Non controlling interests IFRSCurrentQuarterInstant82258000000JPY
Equity IFRSPrior1YearInstant3848727000000JPY
Equity IFRSCurrentQuarterInstant4141838000000JPY
Liabilities and equity IFRSPrior1YearInstant8370732000000JPY
Liabilities and equity IFRSCurrentQuarterInstant8262786000000JPY
Revenue IFRSPrior1YTDDuration1569892000000JPY
Revenue IFRSCurrentYTDDuration1734543000000JPY
Cost of sales IFRSPrior1YTDDuration682278000000JPY
Cost of sales IFRSCurrentYTDDuration730779000000JPY
Gross profit IFRSPrior1YTDDuration887614000000JPY
Gross profit IFRSCurrentYTDDuration1003764000000JPY
Other operating income IFRSPrior1YTDDuration15777000000JPY
Other operating income IFRSCurrentYTDDuration6934000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration3996000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration6703000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration474725000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration537530000000JPY
Operating profit loss IFRSPrior1YTDDuration432662000000JPY
Operating profit loss IFRSCurrentYTDDuration479871000000JPY
Finance income IFRSPrior1YTDDuration31485000000JPY
Finance income IFRSCurrentYTDDuration37145000000JPY
Finance costs IFRSPrior1YTDDuration65074000000JPY
Finance costs IFRSCurrentYTDDuration79196000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-12-31pass
balance sheet identityconsolidated 2025-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass